Inmune Bio, Inc. (INMB) AI Dilution Summary

INMB reported cash of $18,411,000 at 2026-06-30 against estimated monthly burn of $1,058,333. It funds itself through an active ATM program with A.G.P./Alliance Global Partners, and its most recent capital raised was ATM sales through 2026-08-06: 100,000 shares sold after the 2026-06-30 balance-sheet date, for $200,000 net. Dilution here is driven primarily by that ATM, which is authorised to $65,000,000.